Please check your internet connection and try again.
# Chymosin forte
## Overview
Chymosin forte is a combination product containing chymotrypsin and trypsin, proteolytic enzymes derived from animal sources. These enzymes are thought to possess anti-inflammatory and mucolytic properties.
## Primary Indications
* Management of inflammation and edema associated with surgical procedures.
* Treatment of inflammatory conditions, such as hematomas and soft tissue injuries.
* Adjunctive therapy in respiratory conditions with excessive mucus production.
## Adult Dosing
* **Inflammation/Edema/Surgical Support:** Typically administered as 1-2 tablets orally 2-4 times daily. Some formulations may be administered buccally (dissolved under the tongue) or as an intramuscular injection. Specific dosing depends on the severity of the condition and the formulation.
* **Respiratory Conditions:** Dosing varies by formulation. Oral administration is common.
*It is crucial to consult the specific product monograph for exact dosing recommendations as formulations and concentrations vary widely.*
## Pediatric Dosing
There is **limited established pediatric dosing** for chymosin forte. Use in children is generally not recommended or should be approached with extreme caution under specialist guidance.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustments are typically recommended, but caution may be advised in severe renal impairment due to potential for systemic absorption.
* **Hepatic Impairment:** No specific dose adjustments are typically recommended.
## Contraindications
* Known hypersensitivity to chymotrypsin, trypsin, or any component of the formulation.
* Conditions where proteolysis is contraindicated or could be harmful (e.g., severe sepsis, severe liver disease, severe kidney disease).
* Use with caution in patients with known bleeding disorders or those on anticoagulant therapy.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, diarrhea, abdominal discomfort.
* **Allergic Reactions:** Rash, itching, bronchospasm, anaphylaxis (rare).
* **Local Reactions (if injected):** Pain, swelling, redness at the injection site.
* **Taste Disturbances:** Unpleasant taste in the mouth.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Concomitant use may theoretically increase the risk of bleeding. Monitor closely.
* **Antibiotics:** Some evidence suggests proteolytic enzymes may enhance antibiotic penetration into inflamed tissues, but this is not definitively established.
## Monitoring
* Monitor for signs and symptoms of allergic reactions.
* Monitor for gastrointestinal side effects.
* Monitor for signs of bleeding, especially in patients on anticoagulants or with pre-existing bleeding disorders.
## Clinical Pearls
* Chymosin forte is often used as an adjunctive therapy.
* Absorption from oral administration can be variable. Buccal administration may lead to more rapid systemic absorption.
* The efficacy of chymosin forte for many of its indicated uses is based on limited robust clinical trial data.
***
*Disclaimer: This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and professional guidelines before making any clinical decisions. Product formulations and indications can change.*